Verastem (VSTM) Other Accumulated Expenses (2011 - 2026)

Verastem's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $857000.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 49.79% year-over-year to $857000.0 in Q1 2026; TTM through Mar 2026 was $857000.0, a 49.79% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, up 805.41% from the prior year.
• Other Accumulated Expenses eased to $857000.0 in Q1 2026 per VSTM's latest filing, from $3.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $12.6 million in Q2 2022 and bottomed at $183000.0 in Q2 2025.
• The 5-year median for Other Accumulated Expenses is $1.2 million (2024), against an average of $3.2 million.
• Across the five-year window, Other Accumulated Expenses sank 92.31% in 2024 and soared 805.41% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $996000.0 in 2022, then grew by 8.13% to $1.1 million in 2023, then tumbled by 69.08% to $333000.0 in 2024, then surged by 805.41% to $3.0 million in 2025, then tumbled by 71.58% to $857000.0 in 2026.
• Per Business Quant, the three latest VSTM Other Accumulated Expenses figures stand at $857000.0 (Q1 2026), $3.0 million (Q4 2025), and $2.0 million (Q3 2025).